High-resolution low-cost LCD 3D printing of microfluidics

Houda Shafique,Vahid Karamzadeh,Geunyong Kim,Yonatan Morocz,Ahmad Sohrabi-Kashani,Molly L. Shen,David Juncker
DOI: https://doi.org/10.1101/2023.12.31.573772
2024-01-02
Abstract:The fabrication of microfluidic devices has progressed from cleanroom manufacturing to replica molding in polymers, and more recently to direct manufacturing by subtractive (e.g., laser machining) and additive (e.g., 3D printing) techniques, notably digital light processing (DLP) photopolymerization. However, many methods require technical expertise and while DLP 3D printers remain expensive at a cost ∼15-30K USD with ∼8M pixels that are 25-40 µm in size. Here, we introduce (i) the use of low-cost (∼150-600 USD) liquid crystal display (LCD) photopolymerization 3D printing with ∼8M-58M pixels that are 18-35 µm in size for direct microfluidic device fabrication and (ii) a poly(ethylene glycol) diacrylate-based ink developed for LCD 3D printing (PLInk). We optimized PLInk for high resolution, fast 3D printing and biocompatibility while considering the illumination inhomogeneity and low power density of LCD 3D printers. We made lateral features as small as 75 µm, 22-µm-thick embedded membranes, and circular channels with a 110 µm radius. We 3D printed microfluidic devices previously manufactured by other methods, including an embedded 3D micromixer, a membrane microvalve, and an autonomous capillaric circuit (CC) deployed for interferon-γ detection with excellent performance (limit of detection: 12 pg mL , CV: 6.8%), and we demonstrated compatibility with cell culture. Finally, large area manufacturing was illustrated by printing 42 CCs with embedded microchannels in <45 min. LCD 3D printing together with tailored inks pave the way for democratizing access to high-resolution manufacturing of ready-to-use microfluidic devices by anyone, anywhere.
Bioengineering
What problem does this paper attempt to address?
The main problems that this paper attempts to solve are the high manufacturing cost and complex technology of microfluidic devices. Specifically, the paper introduces a method of directly manufacturing microfluidic devices using a low - cost (about $150 - 600) liquid - crystal - display (LCD) photopolymerization 3D printing technology, and develops an ink (PLInk) based on polyethylene glycol diacrylate (PEGDA) for LCD 3D printing. This method not only reduces the manufacturing cost, but also improves the resolution and printing speed, while ensuring biocompatibility. ### Main research objectives: 1. **Reduce cost**: Reduce the manufacturing cost of microfluidic devices by using a low - cost LCD 3D printer. 2. **Improve resolution**: Achieve the manufacturing of microfluidic devices with high resolution (pixel size of 18 - 35 µm). 3. **Increase printing speed**: Optimize the ink formula to achieve fast 3D printing. 4. **Ensure biocompatibility**: Ensure that the printing materials are non - toxic to cells and suitable for biomedical applications. ### Specific methods: - **Hardware**: Use low - cost LCD 3D printers, which have a high number of pixels (8M - 58M pixels) and a small pixel size (18 - 50 µm). - **Ink formula**: Develop an ink (PLInk) based on PEGDA, which contains a photoinitiator (TPO), a light absorber (ITX) and a cross - linker (PETTA), to adapt to the low light intensity and light inhomogeneity of LCD 3D printers. - **Testing and verification**: Verify the feasibility and performance of this method by printing and testing a variety of microfluidic devices, including embedded 3D mixers, membrane microvalves and autonomous capillary circuits (CC). ### Main achievements: - Achieve high - precision printing of embedded membranes with lateral features as small as 75 µm and a thickness of 22 µm, and circular channels with a radius of 110 µm. - Successfully print a variety of microfluidic devices, including embedded 3D mixers, membrane microvalves and autonomous capillary circuits (CC), and show good biocompatibility in cell culture. - Demonstrate the potential for large - scale manufacturing and high - throughput production capacity by printing 42 CCs at a time. ### Conclusion: This research successfully realizes the manufacturing of high - resolution, fast, and biocompatible microfluidic devices through low - cost LCD 3D printing technology and an optimized ink formula, providing a new way for the popularization and application of microfluidic technology.